Company: FCRX
Filing Date: 2025-11-03
Form Type: 8-K
Source: 0001193125-25-262594
Chunk: 1

Company: Crescent Capital BDC, Inc.
Filing Date: 2025-11-03
Form: 8-K
Item: Item 1.01
Chunk 1
---
 February 16, 2026. The issuance of the Tranche C notes is expected to occur on May 22, 2026, subject to customary closing conditions. In addition, the Company will be obligated to offer to repay the Series 2025A Notes at par if certain change in control events occur. The Series 2025A Notes are general unsecured obligations of the Company that rank pari passu with all outstanding and future unsecured unsubordinated indebtedness issued by the Company.

The Company intends to use the net proceeds to repay certain indebtedness, which may include repaying indebtedness outstanding under its debt facilities, and for other general corporate purposes. The Company may

re-borrow

under its debt facilities for general corporate purposes, which include investing in portfolio companies in accordance with its investment objective.

The Note Purchase Agreement contains customary terms and conditions for senior unsecured notes issued in a private placement, including, without limitation, affirmative and negative covenants such as information reporting, maintenance of the Company’s status as a business development company within the meaning of the Investment Company Act of 1940, as amended, and a regulated investment company under the Internal Revenue Code of 1986, as amended, minimum shareholders’ equity, minimum asset coverage ratio, minimum interest coverage ratio and prohibitions on certain fundamental changes of the Company. The Note Purchase Agreement also contains customary events of default with customary cure and notice periods, including, without limitation, nonpayment, incorrect representation in any material respect, breach of covenant, cross-default under other indebtedness of the Company or certain significant subsidiaries, certain judgements and orders, and certain events of bankruptcy.

The Series 2025A Notes were offered in reliance on Section 4(a)(2) of Securities Act of 1933, as amended (the “ Securities Act”). The Series 2024A Notes have not been and will not be registered under the Securities Act or any state securities laws and, unless so registered, may not be offered or sold in the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act, as applicable.

The information on this Current Report on Form

8-K

shall not constitute an offer to sell or a solicitation of an offer to purchase the Series 2025A Notes or any other securities, and shall not constitute an offer, solicitation or sale in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful.

The description above is only a summary of the